Skip to content

Robot-assisted versus open lateral pancreaticojejunostomy for the treatment of symptomatic chronic pancreatitis (PANACOTTA)

Robot-assisted versus open lateral pancreaticojejunostomy for the treatment of symptomatic chronic pancreatitis (PANACOTTA): a multicenter patient- and assessor-blinded randomized trial - PANACOTTA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57233
Enrollment
25
Registered
2024-06-24
Start date
2025-04-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pancreatitis Chronic pancreatitis

Interventions

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. At least 18 years old 2. Indication for lateral pancreaticojejunostmy as agreed during  multidisciplinary team meeting based on symptomatic CP (i.e. morphine dependent pain or recurrent acute pancreatitis) 3. Dilated pancreatic duct of >= 5 mm, without enlarged pancreatic head < 40 mm 4. Confirmed CP, according to the M-ANNHEIM diagnostic  Criteria22 • Typical clinical history of chronic pancreatitis (i.e. recurrent pancreatitis or abdominal pain), and: • One or more of the following additional criteria for the diagnosis of CP: o Pancreatic calcifications on CT or MRI imaging. o Moderate or marked ductal lesions (according to the Cambridge classification)  on endoscopic retrograde cholangiopancreatography (ERCP) or magnetic resonance  cholangiopancreatography (MRCP) imaging. o Marked and persistent exocrine insufficiency (defined as: a. pancreatic  steatorrhea clearly relieved by enzyme supplementation, and/or b. fecal  elastase levels of <= 200 micro gram/gram). 5. Eligible for both a robot-assisted and open approach 6. Obtained written informed consent

Exclusion criteria

Exclusion criteria: 1. Suspected or confirmed current pancreatic malignancy 2. Known allergy / contraindication for epidural anesthesia 3. ASA classification >= 4 4. Other painful conditions aside from chronic pancreatitis, making it unable  differentiate between pain related to chronic pancreatitis and pain stemming  from other sources 5. Prior pancreatic surgery  6. Pregnancy

Design outcomes

Primary

MeasureTime frame
Primary: Quality of recovery as measured by the QoR-15.

Secondary

MeasureTime frame
Secondary: blood loss, total operative time, complications (surgical site infection, delayed gastric emptying, postoperative pancreatic fistula, postpancreatectomy haemorrhage), cumulative opioid consumption, all-cause mortality, time to functional recovery, area under the curve of QoR-15 until conditions of time to functional recovery are met, hospital stay, readmission(s) for any indication, quality of life, costs, endoscopic interventions, surgical interventions, new-onset endocrine pancreatic insufficiency, new-onset exocrine pancreatic insufficiency, pain (Izbicki pain score, COMPAT, NRS), disease progression.

Countries

Germany, Netherlands

Contacts

Public ContactE. Kilinc

Amsterdam UMC

e.kilinc@amsterdamumc.nl020 444 4444

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026